Maen Abdelrahim Download Headshot

Maen Abdelrahim, MD, PhD, B Pharm

  • Houston Methodist gastrointestinal medical oncologist
  • Assistant Professor of Medicine in Oncology, Houston Methodist Institute for Academic Medicine
  • Director, Houston Methodist Cockrell Center for Advanced Therapeutics
  • Assistant Professor of Medicine, Weill Cornell Medical College
Media Contact: Daniel Brown , 832.667.5849

Maen Abdelrahim, MD, PhD, B Pharm

Request Interview
Media Contact: Daniel Brown , 832.667.5849

Areas of Expertise

  • Cancer clinical trials
  • Cholangiocarcinoma
  • Clinical research
  • Colon cancer
  • Esophageal cancer
  • Gastric cancer
  • Gastrointestinal stromal tumors (GIST)
  • Liver cancer
  • Neuroendocrine cancers
  • Pancreatic cancer
  • Rectal cancer
  • Small intestine cancer
  • Translation research

Credentials

BACHELOR OF PHARMACY
Isra University - Amman, Jordan
DOCTOR OF PHILOSOPHY
Pharmacology and Toxicology | Texas A&M University - College Station, Texas
MEDICAL SCHOOL
Texas A&M University College of Medicine - Houston, Texas
RESIDENCY
Internal Medicine | Baylor College of Medicine - Houston, Texas
FELLOWSHIP
Medical Oncology | Duke University School of Medicine - Durham, N.C.

Publications

Sorafenib as Adjuvant Therapy Post-Liver Transplant: A Single-center Experience
Hassanain, H, Connor, AA, Brombosz, EW, Patel, K, Elaileh, A, Basra, T, Kodali, S, Victor, DW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Saharia, A, Dhingra, S, Schwartz, M, Maqsood, A, Heyne, K, Kaseb, AO, Vauthey, JN, Gaber, AO, Abdelrahim, M & Ghobrial, RM 2025, , Transplantation Direct, vol. 11, no. 2, pp. e1746. https://doi.org/10.1097/TXD.0000000000001746

Chapter 18 - History of cancer and transplant clearance: Considerations prior to transplantation
Esmail, A & Abdelrahim, M 2024, . in MA Abdelrahim (ed.), Transplant Oncology: A Frontier in Multidisciplinary Cancer Care. Elsevier, pp. 215-228. https://doi.org/10.1016/B978-0-443-21901-6.00018-5

Chapter 8 - Transplant oncology and immunotherapy: Immunotherapy and liver transplants: Immunotherapy and liver transplants
Abdelrahim, M & Esmail, A 2024, . in MA Abdelrahim (ed.), Transplant Oncology: A Frontier in Multidisciplinary Cancer Care. Elsevier, pp. 87-105. https://doi.org/10.1016/B978-0-443-21901-6.00008-2

Chapter 24 - Patient characteristics and evaluations prior to liver transplantation
Abdelrahim, M, Alqahtani, A, Esmail, A & Al-Judaibi, B 2024, . in MA Abdelrahim (ed.), Transplant Oncology: A Frontier in Multidisciplinary Cancer Care. Elsevier, pp. 277-293. https://doi.org/10.1016/B978-0-443-21901-6.00024-0

Outcomes of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation Utilizing Extended Criteria Donor Grafts
Brombosz, EW, Hobeika, MJ, Kodali, S, Connor, AA, Saharia, A, Mobley, CM, Simon, CJ, Cheah, YL, Abdelrahim, M, Victor, DW, Graviss, EA, Nguyen, DT, Moore, LW & Ghobrial, RM 2024, , Transplantation Proceedings, vol. 56, no. 10, pp. 2203-2212. https://doi.org/10.1016/j.transproceed.2024.10.039

The association between different molecular alterations in Wnt/ß-catenin signaling and response to treatment with immune checkpoint inhibitors in solid tumors
Khushman, M, Abushukair, HM, Modekurty, S, Patel, GK, Abdelrahim, M, Esmail, A, Baral, MR & Singh, AP 2024, , J Immunother Cancer, vol. 12, no. Suppl 2, pp. A192. https://doi.org/10.1136/jitc-2024-SITC2024.0169

The association between alterations in the ataxia telangiectasia mutated (ATM) gene and response to immune checkpoint inhibitors
Baral, MR, Abushukair, HM, Abdelrahim, M, Esmail, A, Diffalha, SAL, Manne, U & Khushman, M 2024, , J Immunother Cancer, vol. 12, no. Suppl 2, pp. A170. https://doi.org/10.1136/jitc-2024-SITC2024.0151

Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Botta, GP, Abdelrahim, M, Drengler, RL, Aushev, VN, Esmail, A, Laliotis, G, Brewer, CM, George, GV, Abbate, SM, Chandana, SR, Tejani, MA, Malla, M, Bansal, D, Rivero-Hinojosa, S, Spickard, E, McCormick, N, Cecchini, M, Lacy, J, Fei, N, Kasi, PM, Kasi, A, Dayyani, F, Hanna, DL, Sharma, S, Malhotra, M, Aleshin, A, Liu, MC & Jurdi, A 2024, , Oncologist, vol. 29, no. 10, pp. 859-869. https://doi.org/10.1093/oncolo/oyae155


The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
Esmail, A, Xu, J, Burns, EA, Abboud, K, Sheikh, A, Umoru, G, Gee, K, Wiechmann, C, Zhang, Y & Abdelrahim, M 2024, , Journal of Clinical Medicine, vol. 13, no. 17, 4994. https://doi.org/10.3390/jcm13174994

Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Botta, GP, Abdelrahim, M, Drengler, RL, Aushev, VN, Esmail, A, Laliotis, G, Brewer, CM, George, GV, Abbate, SM, Chandana, SR, Tejani, MA, Malla, M, Bansal, D, Rivero-Hinojosa, S, Spickard, E, McCormick, N, Cecchini, M, Lacy, J, Fei, N, Kasi, PM, Kasi, A, Dayyani, F, Hanna, DL, Sharma, S, Malhotra, M, Aleshin, A, Liu, MC & Jurdi, A 2024, , Oncologist. https://doi.org/10.1093/oncolo/oyae155


Advances in Immunotherapy for Transplant Oncology
Abdelrahim, M, Esmail, A, He, AR, Khushman, M & Rayyan, Y 2024, , Cancers, vol. 16, no. 13, 2369. https://doi.org/10.3390/cancers16132369

The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma
Esmail, A, Badheeb, M, Alnahar, BW, Almiqlash, B, Sakr, Y, Al-Najjar, E, Awas, A, Alsayed, M, Khasawneh, B, Alkhulaifawi, M, Alsaleh, A, Abudayyeh, A, Rayyan, Y & Abdelrahim, M 2024, , Pharmaceuticals, vol. 17, no. 7, 910. https://doi.org/10.3390/ph17070910

Advances in Immunotherapy for Transplant Oncology
Abdelrahim, M, Esmail, A, He, AR, Khushman, M & Rayyan, Y 2024, , Cancers, vol. 16, no. 13, 2369. https://doi.org/10.3390/cancers16132369, https://doi.org/10.3390/cancers16132369


Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation
Saleh, Y, Abu Hejleh, T, Abdelrahim, M, Shamseddine, A, Chehade, L, Alawabdeh, T, Mohamad, I, Sammour, M & Turfa, R 2024, , Cancers, vol. 16, no. 11, 2081. https://doi.org/10.3390/cancers16112081

Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma
Abdelrahim, M, Esmail, A, Divatia, MK, Xu, J, Kodali, S, Victor, DW, Brombosz, E, Connor, AA, Saharia, A, Elaileh, A, Kaseb, AO & Ghobrial, RM 2024, , Journal of Clinical Medicine, vol. 13, no. 11, 3068. https://doi.org/10.3390/jcm13113068

Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation
Esmail, A, Badheeb, M, Alnahar, B, Almiqlash, B, Sakr, Y, Khasawneh, B, Al-Najjar, E, Al-Rawi, H, Abudayyeh, A, Rayyan, Y & Abdelrahim, M 2024, , Cancers, vol. 16, no. 11, 1946. https://doi.org/10.3390/cancers16111946

Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation: The Current Status of Surgical Options including Liver Transplantation
Esmail, A, Badheeb, M, Alnahar, B, Almiqlash, B, Sakr, Y, Khasawneh, B, Al-Najjar, E, Al-Rawi, H, Abudayyeh, A, Rayyan, Y & Abdelrahim, M 2024, , Cancers, vol. 16, no. 11. https://doi.org/10.3390/cancers16111946

Languages

  • English
  • Spanish